Daner Li

Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial

Daniel V.T. Catenacci, Yoon‐Koo Kang, Haeseong Park et al. · The Lancet Oncology · 2020 · 186 citations

Oncology, Esophageal Cancer, Gastrointestinal Oncology +7

Improved Obstetric Outcomes and Few Maternal Toxicities Are Associated With Antiretroviral Therapy, Including Highly Active Antiretroviral Therapy During Pregnancy

Ruth Tuomala, D. Heather Watts, Daner Li et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 175 citations

Obstetric Outcomes, Reproductive Health, Gynecology +21

Clinical Significance of Radiologic Characterizations in COPD

MeiLan K. Han, Brian J. Bartholmai, Lyrica X. Liu et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2009 · 93 citations · Full text

Preliminary Results of a Phase 1 Study of Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Geoffrey L. Uy, John E. Godwin, Michael P. Rettig et al. · Blood · 2017 · 62 citations

Assessment of Birth Defects According to Maternal Therapy Among Infants in the Women and Infants Transmission Study

D. Heather Watts, Daner Li, Ed Handelsman et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 57 citations